GE HealthCare Technologies Inc. Common Stock (GEHC) Financial Statements
Historical financial data — 20 statements covering FY2021–FY2025
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), adv...
GE HealthCare Technologies Inc. Common Stock's revenue increased 4.8% year over year, from $19.67B to $20.63B.
Net income increased 4.6% over the same period, from $1.99B to $2.08B.
Over the 4-year period from FY2021 to FY2025, revenue grew by 17% in total.
Total debt increased by 11.8% to $10.00B.
The debt-to-equity ratio stands at 0.96, indicating a moderate leverage profile.
Operating cash flow grew 1.6% to $1.99B.
GE HealthCare Technologies Inc. Common Stock maintains a healthy net profit margin of 10.1%.
Recent Financial Statements
Quarterly figures are standalone quarters, de-cumulated from YTD filings (Q4 = FY − Q3 YTD when not reported).
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2024 | $4.86B+0.5% | $470.0M | $2.03B | $676.0M | $742.0M | $33.85B | $10.31B | $8.32B |
| Q4 FY2024 | $5.32B+9.4% | $721.0M | $2.27B | $801.0M | $913.0M | $33.09B | $8.95B | $8.45B |
| Q1 FY2025 | $4.78B-10.2% | $564.0M | $2.01B | $629.0M | $250.0M | $33.59B | $8.76B | $9.19B |
| Q2 FY2025 | $5.01B+4.8% | $485.0M | $1.99B | $654.0M | $94.0M | $35.50B | $10.28B | $9.71B |
| Q3 FY2025 | $5.14B+2.7% | $446.0M | $1.99B | $653.0M | $593.0M | $36.13B | $10.28B | $9.99B |
| Q4 FY2025 | $5.70B+10.8% | $589.0M | $2.26B | $827.0M | $1.05B | $36.91B | $10.00B | $10.38B |
| Q1 FY2026 | $5.13B-10.0% | $389.0M | $1.98B | $515.0M | $290.0M | N/A | N/A | N/A |
| Q2 FY2026 | $5.29B+3.2% | $561.0M | $2.18B | $739.0M | $168.0M | N/A | N/A | N/A |
Balance Sheet Summary (FY2025)
GE HealthCare Technologies Inc. Common Stock (GEHC) Financial Statements & Revenue History
GE HealthCare Technologies Inc. Common Stock (GEHC) is a US-listed stock operating in the Healthcare sector, specifically the X-Ray Apparatus & Tubes & Related Irradiation Apparatus industry trading at $69.57 with a market capitalization of $31. This page provides 20 historical financial statements for GE HealthCare Technologies Inc. Common Stock, including income statement, balance sheet, and cash flow data across multiple reporting periods. Most recently, GE HealthCare Technologies Inc. Common Stock reported revenue of $20.6 billion, representing 4.8% year-over-year growth. The net profit margin of 10.1% indicates moderate profitability. The debt-to-equity ratio of 0.96 reflects moderate leverage.
GEHC Income Statement, Balance Sheet & Cash Flow
The financial statements table above shows GE HealthCare Technologies Inc. Common Stock's revenue, net income, gross profit, EBIT, operating cash flow, total assets, total debt, and shareholders' equity across the most recent reporting periods. Year-over-year growth rates help identify whether GEHC is accelerating or decelerating in terms of top-line revenue and bottom-line profitability.
- Revenue trend: Track GEHC's top-line growth across quarters and fiscal years to identify acceleration or deceleration in the business.
- Profitability: Net income and gross profit margins reveal how efficiently GE HealthCare Technologies Inc. Common Stock converts revenue into earnings.
- Balance sheet health: Total assets, liabilities, debt, and equity provide a snapshot of GEHC's financial position and leverage.
- Cash flow: Operating cash flow shows how much cash the business generates from its core operations, which is critical for funding dividends, buybacks, and growth.
How to Use GEHC Financial Data
Investors use GE HealthCare Technologies Inc. Common Stock's financial statements to assess the company's financial health, growth trajectory, and valuation. Key metrics to focus on include:
- Revenue growth rate: Consistent double-digit revenue growth suggests a strong business; declining revenue may signal competitive pressure.
- Net profit margin: Higher margins indicate a more efficient business with pricing power. Compare GEHC's margins to sector peers for context.
- Debt levels: High debt-to-equity ratios increase financial risk, especially in rising-rate environments. Low debt provides flexibility.
- Valuation multiples: See how GEHC's P/E, P/S, and EV/EBITDA ratios compare to historical levels.
- Full analysis: View GEHC's financial health score, earnings, and pre-market pricing.
Financial data is sourced from GE HealthCare Technologies Inc. Common Stock's SEC filings (10-K, 10-Q) via Polygon.io and Finnhub.GEHC trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.